Metabolic genetics, body composition, current eating patterns, and stress levels all influence how quickly appetite suppression translates to fat loss
Obstructive Sleep Apnea SURMOUNT-OSA trials investigated GLP2 in adults with moderate-to-severe obstructive sleep apnea and obesity: Significant improvements in apnea-hypopnea index (AHI) from baseline Benefits observed in participants both using and not using positive airway pressure therapy Improvements correlated with weight reduction FDA approval granted in December 2024 for moderate-to-severe OSA treatment Diabetes Prevention Extended follow-up from SURMOUNT-1 assessed diabetes prevention in participants with prediabetes: 94% reduction in progression to type 2 diabetes compared to placebo over 3 years Nearly all participants with prediabetes at baseline converted to normoglycemia Effects diminished during off-treatment follow-up period, indicating ongoing treatment benefit [CALLOUT BOX Highlighted] Important Context: While GLP2 has demonstrated substantial efficacy in multiple large-scale clinical trials, the majority of data comes from industry-sponsored studies with relatively short follow-up periods (40-72 weeks for most trials)
Supplementation of soybean lecithin-based semen extender by antioxidants: Complementary flowcytometric study on post-thawed ram spermatozoa
Current evidence does not support a direct causal relationship between Ozempic and anger issues, but individual experiences may vary, and further research into the psychological effects of GLP-1 agonists would be valuable
For one thing, a growing income stream can help you keep up with inflation over time
Youre worth it
